Literature DB >> 27308558

Paracrine WNT5A signaling in healthy and neoplastic mammary tissue.

David Kusner1, Nicholas Borcherding2, Weizhou Zhang3.   

Abstract

Paracrine signaling between mammary epithelial cells has long been appreciated. Recently, we found that Wnt5a, a novel noncanonical Wnt ligand of luminal origin, counteracts canonical Wnt signaling in basal mammary epithelial cells through a paracrine pathway, inhibits the expansion of Erbb2-induced tumor-initiating cells, and suppresses tumor incidence and metastasis.

Entities:  

Keywords:  Breast cancer; Noncanonical WNT; WNT5A signaling; mammary development

Year:  2015        PMID: 27308558      PMCID: PMC4845198          DOI: 10.1080/23723556.2015.1040145

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN: 2372-3556


  10 in total

1.  Generation of a functional mammary gland from a single stem cell.

Authors:  Mark Shackleton; François Vaillant; Kaylene J Simpson; John Stingl; Gordon K Smyth; Marie-Liesse Asselin-Labat; Li Wu; Geoffrey J Lindeman; Jane E Visvader
Journal:  Nature       Date:  2006-01-05       Impact factor: 49.962

2.  Purification and unique properties of mammary epithelial stem cells.

Authors:  John Stingl; Peter Eirew; Ian Ricketson; Mark Shackleton; François Vaillant; David Choi; Haiyan I Li; Connie J Eaves
Journal:  Nature       Date:  2006-01-04       Impact factor: 49.962

3.  Progesterone induces adult mammary stem cell expansion.

Authors:  Purna A Joshi; Hartland W Jackson; Alexander G Beristain; Marco A Di Grappa; Patricia A Mote; Christine L Clarke; John Stingl; Paul D Waterhouse; Rama Khokha
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

4.  Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells.

Authors:  Alison E Obr; Sandra L Grimm; Kathleen A Bishop; J Wesley Pike; John P Lydon; Dean P Edwards
Journal:  Mol Endocrinol       Date:  2013-09-06

5.  Control of mammary stem cell function by steroid hormone signalling.

Authors:  Marie-Liesse Asselin-Labat; François Vaillant; Julie M Sheridan; Bhupinder Pal; Di Wu; Evan R Simpson; Hisataka Yasuda; Gordon K Smyth; T John Martin; Geoffrey J Lindeman; Jane E Visvader
Journal:  Nature       Date:  2010-04-11       Impact factor: 49.962

6.  Reversible inhibition of mammary gland growth by transforming growth factor-beta.

Authors:  G B Silberstein; C W Daniel
Journal:  Science       Date:  1987-07-17       Impact factor: 47.728

7.  Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk.

Authors:  Renuga Devi Rajaram; Duje Buric; Marian Caikovski; Ayyakkannu Ayyanan; Jacques Rougemont; Jingdong Shan; Seppo J Vainio; Ozden Yalcin-Ozuysal; Cathrin Brisken
Journal:  EMBO J       Date:  2015-01-20       Impact factor: 11.598

8.  Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating Cells.

Authors:  Nicholas Borcherding; David Kusner; Ryan Kolb; Qing Xie; Wei Li; Fang Yuan; Gabriel Velez; Ryan Askeland; Ronald J Weigel; Weizhou Zhang
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

9.  Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth.

Authors:  Kevin Roarty; Rosa Serra
Journal:  Development       Date:  2007-09-26       Impact factor: 6.868

10.  Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.

Authors:  Kevin Roarty; Sarah E Baxley; Michael R Crowley; Andra R Frost; Rosa Serra
Journal:  Breast Cancer Res       Date:  2009-04-03       Impact factor: 6.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.